RTI Surgical (NASDAQ:RTIX) was upgraded by BidaskClub from a “strong sell” rating to a “sell” rating in a note issued to investors on Saturday.
Separately, Zacks Investment Research lowered RTI Surgical from a “hold” rating to a “sell” rating in a research report on Thursday, October 5th.
RTI Surgical (NASDAQ:RTIX) traded up $0.15 during mid-day trading on Friday, reaching $4.45. The company had a trading volume of 414,364 shares, compared to its average volume of 184,346. RTI Surgical has a one year low of $3.01 and a one year high of $6.00. The company has a current ratio of 3.34, a quick ratio of 1.21 and a debt-to-equity ratio of 0.25. The company has a market cap of $261.58, a price-to-earnings ratio of -63.57, a PEG ratio of 1.91 and a beta of 1.76.
A number of hedge funds have recently bought and sold shares of RTIX. Prudential Financial Inc. bought a new position in RTI Surgical during the 3rd quarter valued at approximately $111,000. Citadel Advisors LLC increased its position in RTI Surgical by 85.7% during the 3rd quarter. Citadel Advisors LLC now owns 26,786 shares of the medical equipment provider’s stock valued at $122,000 after buying an additional 12,361 shares in the last quarter. Citigroup Inc. increased its holdings in shares of RTI Surgical by 2,850.1% in the 2nd quarter. Citigroup Inc. now owns 21,152 shares of the medical equipment provider’s stock worth $124,000 after purchasing an additional 20,435 shares in the last quarter. Campbell & CO Investment Adviser LLC bought a new stake in shares of RTI Surgical in the 3rd quarter worth $144,000. Finally, Thompson Davis & CO. Inc. increased its holdings in shares of RTI Surgical by 138.8% in the 2nd quarter. Thompson Davis & CO. Inc. now owns 25,077 shares of the medical equipment provider’s stock worth $147,000 after purchasing an additional 14,577 shares in the last quarter. 69.90% of the stock is owned by institutional investors.
COPYRIGHT VIOLATION NOTICE: “RTI Surgical (RTIX) Rating Increased to Sell at BidaskClub” was reported by American Banking News and is owned by of American Banking News. If you are reading this piece on another publication, it was illegally copied and republished in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.americanbankingnews.com/2018/01/06/rti-surgical-rtix-rating-increased-to-sell-at-bidaskclub.html.
About RTI Surgical
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.